Are all outside directors created equal with respect to firm disclosure policy?

被引:0
|
作者
Luminita Enache
Antonio Parbonetti
Anup Srivastava
机构
[1] University of Calgary,Haskayne School of Business
[2] University of Padua,Department of Economics and Management
关键词
Biotechnology firms; Corporate governance; Voluntary disclosures; Proprietary costs; Outside directors; M40; M41; G14; G32; G34;
D O I
暂无
中图分类号
学科分类号
摘要
Empirical evidence on the association between outside directors and firms’ voluntary disclosures is mixed and controversial. We hypothesize that the outside directors do not represent a homogeneous group of people as considered in the literature. Using hand-collected data from a sample of biotechnology firms, we find that the aforesaid association differs based on the directors’ professional backgrounds. Our results are consistent with two ideas. First, an outside director’s influence on firm disclosure policy is shaped by her professional background. Second, firms match outside directors’ professional backgrounds with their disclosure policy. We cannot distinguish between the two explanations. Yet, we make an important contribution to the literature. We show that the impact and the selection prospects of outside directors are not as uniform as previously considered in the literature. Thus, the researchers examining financial disclosures must take into account the background characteristics of all outside directors, not just of those in the audit committee. And investor bodies must consider the background characteristics of candidates in their recommendation for outside-director selection.
引用
收藏
页码:541 / 577
页数:36
相关论文
共 50 条
  • [1] Are all outside directors created equal with respect to firm disclosure policy?
    Enache, Luminita
    Parbonetti, Antonio
    Srivastava, Anup
    REVIEW OF QUANTITATIVE FINANCE AND ACCOUNTING, 2020, 55 (02) : 541 - 577
  • [2] Not all faultlines are created equal: The heterogeneous impact of TMT faultlines on a firm's ESG disclosure
    Pan, Chao
    Su, Xin
    Zhong, Xi
    BUSINESS ETHICS THE ENVIRONMENT & RESPONSIBILITY, 2025, 34 (02): : 489 - 506
  • [4] NOT ALL PIXELS ARE CREATED EQUAL
    Grotta, Sally Wiener
    Grotta, Daniel
    IEEE SPECTRUM, 2012, 49 (05) : 22 - 24
  • [5] All epoxies are not created equal
    Wiggins, Janell
    Aberdeen's Concrete Repair Digest, 1996, 7 (03): : 144 - 146
  • [6] ALL HYPOXEMIA IS NOT CREATED EQUAL
    Kubota-Mishra, E. A.
    Agwu, A. V.
    Evangelista, M. S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (02) : 494 - 494
  • [7] All troponins are not created equal
    Jossi, S
    Gordon, SL
    Legge, MA
    Armstrong, GP
    INTERNAL MEDICINE JOURNAL, 2006, 36 (05) : 325 - 327
  • [8] All progestins are not created equal
    Stanczyk, FZ
    STEROIDS, 2003, 68 (10-13) : 879 - 890
  • [9] All nanocarriers are created equal
    Park, Kinam
    JOURNAL OF CONTROLLED RELEASE, 2008, 130 (02) : 139 - 139
  • [10] Not all perfluorochemicals are created equal
    Halamek, LP
    Dimmitt, RA
    Mickas, NA
    CRITICAL CARE MEDICINE, 2000, 28 (08) : 3132 - 3132